This $2 Stock Outshines Historic Gold Rally!

Gold has soared 25% in the last 6 months, but this young company has more than doubled that return. With a price target nearly double its current value, it's caught the eye of 40+ investment banks and funds. Discover the name of this standout company today and see why it's a potential gold mine for investors.

What's Going On With Tonix Pharmaceuticals (TNXP) Stock?

Henry Khederian
August 20, 2024

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares were trading lower Tuesday, closing down 14.61% at 38 cents. The stock is pulling back after gaining as much as 60% during Monday’s session after the company reported second-quarter financial results.

The company early Tuesday also said it initiated a Phase 2 trial of TNX-1300, a treatment for acute cocaine intoxication, aiming to rapidly degrade cocaine in the body.

The study, supported by NIDA and with FDA Breakthrough Therapy designation, will test the safety and effectiveness of TNX-1300 in 60 patients across six U.S. emergency departments. The primary focus is on reducing systolic blood pressure within 60 minutes after treatment.

Read Also: AMD Bets Big On AI With $4.9B ZT Systems Deal: Goldman Sachs Highlights ‘1,000 Engineers’ Driving Competitive Edge

What Happened With Earnings?

Tonix Pharmaceuticals reported a GAAP earnings per share (EPS) loss of $19.28, which was below the estimated loss of $3.27. Sales for the quarter were $2.208 million, missing the estimated $3.500 million.

Tonix Pharmaceuticals highlighted progress on its TNX-801 vaccine candidate, aimed at preventing mpox (formerly monkeypox) and smallpox. In June 2024, the company presented preclinical data showing that TNX-801, a live attenuated vaccine based on horsepox, effectively protected non-human primates from lethal mpox infection.

The vaccine demonstrated the ability to prevent clinical disease, reduce viral shedding and potentially block transmission.

This comes as the World Health Organization (WHO) recently declared mpox in Africa a public health emergency of international concern, with experts concerned about the spread of a new strain to the U.S.

Tonix says their manufacturing facility in Dartmouth, Massachusetts, is prepared to produce TNX-801 in response to any national or international emergencies.

Read Also: Lowe’s Q2 EPS Beats Expectations, But Slashes FY24 Outlook Amid DIY Sales Slump

Should I Sell My TNXP Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Tonix Pharmaceuticals stock currently has an RSI of 36.33, indicating neutral conditions.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.

TNXP has a 52-week high of $32.32 and a 52-week low of 37 cents

Read Next:
• Jobs Data Could Be Off By 1 Million When Labor Department Revises Figures: What It Means For The Fed

Continue Reading...

Popular

Harris, Trump Films To Hit Theaters Weeks Before 2024 Election: One Candidate Tried To Block Movie From Release

Movies about Kamala Harris and Donald Trump hit theaters in October. Find out the differences between the movie and why one candidate wants a ban.

Scaramucci Says Melania Trump Would Prefer Kamala Harris To Donald Trump As President

Anthony Scaramucci has claimed that Melania Trump would rather see Kamala Harris win the presidency than her own husband.

Discover the $2 Stock That Has Institutional Attention - Ad

With a $1.3B market cap and forecasts to grow 2X faster than the sector, dozens of investment banks are betting big. Strong leadership, cash on hand, and a $3 target make it a must-see.

Trump Vs Harris: The Controversy Over 'No Artificial Lifts' Rule In Tuesday Debate: 'A Form of Cheating!'

Ahead of the much-anticipated debate Tuesday night between Donald Trump and Kamala Harris, Trump has voiced his opinion on the "no artificial lifts" rule.

Top 2 Energy Stocks That Are Ticking Portfolio Bombs

Two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

This Win Rate Puts Buffett to Shame - Ad

He's got a higher win rate than Warren Buffett, Carl Icahn, and Mark Cuban...but you've likely never heard his name. What's most amazing is that his unshakable strategy is working just as well today as it did during our long bull market. Even the Covid crash didn't shake it! He's been on a wild 6-year win streak ( with no signs of slowing down) How does he do it?

Huge payout expected for a rare coin bought by Ohio farm family and hidden for decades

TOLEDO, Ohio (AP) -- Three sisters from Ohio who inherited a dime kept in a bank vault for more than 40 years knew it had some value. But they had no idea just how much until just a few years ago.

Bill Ackman And Elon Musk Blast Kamala Harris For Her Social Media Posts During Debate With Trump: 'Even Her Tweets Are Not Her Own'

Recent comments by prominent figures have sparked debate over Vice President Kamala Harris's social media activity and public engagement. Bill Ackman, CEO of Pershing Square Capital Management, raised questions about Harris's involvement in her own X posts during the recent Republican primary debate.

Oil = Monthly Income - Ad

Right now, there's an unusual $25 way to collect MONTHLY income from the oil markets. It's not a stock, bond, or anything you've likely heard about... But it's by far my #1 investment opportunity for 2024.

E. Jean Carroll Case: Appeals Court Skeptical of Trump's Bid to Overturn Sexual Abuse Verdict

E. Jean Carroll's case sees an appeals court skeptical of Donald Trump's bid to overturn a $5 million verdict for sexual abuse and defamation.

A New Drug Set to Outgrow Zoloft and Metformin--Invest Now - Ad

A new breakthrough drug is predicted to hit 250 million subscriptions in the next SIX YEARS, according to Morgan Stanley. Even better, a tiny company - trading for only $7 - holds key patents on this new drug. But it won't stay under the radar for much longer.

Tron Founder Justin Sun Channels His Innner SBF: 'I'll Buy As Much SUN As You Have At $0.03, Then Go...'

Tron (CRYPTO: TRON) founder Justin Sun recently took to social media to confront critics of his newly launched Sun (CRYPTO: SUN) token, echoing a move reminiscent of former FTX founder

Will Nvidia Continue To Deliver? Investors Sweat Over Hyped-up Expectations And Potential Blackwell Delay Ahead Of Q2 Report

Chipmaker and artificial intelligence stalwart Nvidia Corp. is all set to announce its quarterly results Wednesday after the market close. Analysts are upbeat about the company scaling lofty goals and reigniting the market momentum, which has toned down a bit in recent sessions.

President Trump and Elon Musk Issue Stark Warning - Ad

Both President Trump and Elon Musk are warning about something that could send the market down 50%, real estate down 40% and savings accounts down 30%.

NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership

The cannabis company on Nasdaq has partnered with Vectura Fertin Pharma, to launch a dissolvable tablet that delivers a precise dose of CBD.

Colorado plans to relocate wolf pack as reintroduction effort stumbles amid livestock attacks

Wildlife agencies are trying to capture and relocate the first pack of wolves that formed under Colorado's ambitious after the animals repeatedly , marking an early stumble in the first year of the voter-driven initiative.

Forget AI, Imperium Is Expected to Grow 320,000% In 3 Years - Ad

Three of the world's biggest AI companies -- Google, Nvidia and Intel -- have even partnered with my No. 1 Imperium company to get on this massive mega trend. The average investor hasn't caught on yet, but you can still invest in my No. 1 Imperium company for just $10 a share.

Turkey seeks to join the BRICS bloc of emerging economies, a Kremlin official says

MOSCOW (AP) — NATO member Turkey has applied for membership in the , a senior Kremlin official said Wednesday, as Russia and China seek to counter the West's global influence.

Elon Musk And Trump's Federal Efficiency Plans Slammed By Paul Krugman, Economist Warns About Risks To Medicare, Social Security: 'Government Is An Insurance Company With An Army'

Nobel laureate Paul Krugman has expressed concerns over Republican presidential candidate Donald Trump and Tesla Inc CEO Elon Musk's proposed federal spending cuts. Krugman shared his thoughts on X on Thursday, ahead of the 2024 presidential election.

Analysts Are Projecting "Safe-Haven" Stock Will Nearly Double - Ad

Already up nearly 50% in the last 6 months this gold company has an analyst target nearly twice its current price. With 40+ investment banks and funds already invested it's no wonder this $1.3B company (trading under $2) is grabbing investor attention.

Betting On U.S. Elections? Federal Judge's Decision Greenlights Political Wagers

A federal judge has greenlighted Kalshi to offer U.S. election betting, overturning a 2023 CFTC block, with contracts launching next week.

WHO and Africa CDC launch a response plan to the mpox outbreak

DAKAR, Senegal (AP) — The Africa Center for Disease Control and Prevention and the World Health Organization launched on Friday a continent-wide response plan to the outbreak of mpox, three weeks after WHO declared outbreaks in 12 African countries a .

Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad

The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.

Apple Reportedly Plans To Switch To OLED For All iPhones Starting 2025, Not Just The Top-Tier Flagships

Apple plans to transition all iPhone models, including the lower-priced iPhone SE, to OLED displays by 2025, phasing out LCDs and excluding Japanese suppliers like Japan Display and Sharp from its handset business.

What If Kamala Wins? The 3 Words That Will Change Everything - Ad

The same team that predicted Biden's downfall ... now warns of a new threat. Learn how to safeguard your future.

Nvidia, TSMC Lead Chip Stocks Lower In Premarket: What's Going On

Chip stocks are moving notably lower in premarket trading, and this could potentially serve as a drag for the broader market Tuesday.

New "Living Missile" to Replace Nuclear Missiles - Ad

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

Investigators say dispatching errors led to Union Pacific train crash that killed 2 workers

OMAHA, Neb. (AP) — Dispatching errors combined with the failure of two backup systems allowed a Union Pacific train to that had been parked on a side track for nine months in Southern California two years ago, killing an engineer and a conductor, according to a report issued Thursday.

Brazil Supreme Court panel unanimously upholds judge's decision to block X nationwide

RIO DE JANEIRO (AP) — A Brazilian Supreme Court panel on Monday unanimously upheld the decision of one of its justices to nationwide, according to the court’s website.

4 Cryptos Set to Outperform Bitcoin in 2024 - Ad

Chris Rowe, the man who spotted 44 different coins that have returned over 100%, is now making the biggest crypto call of his ENTIRE career.... Because a powerful crypto event will trigger on June 24th... Sending hundreds of tiny cryptos soaring 5X, 50X, even 100X -- in just days.

Social media is filled with skin care routines for girls. Here's what dermatologists recommend

Girls are with advice from influencers touting elaborate skin care routines with high-priced serums, mists and creams. But what is the right skin care routine for preteens?

Arthur Hayes: 'Plentiful Filthy Fiat Money' Could Stimulate The Economy Ahead Of November Election

Cryptocurrency industry veteran and BitMEX co-founder Arthur Hayes on Wednesday suggested that the Federal Reserve’s upcoming monetary policy decisions could be strategically aligned with the November U.S.

Don't Tell ANYONE About This Altcoin (Until It Pops)... - Ad

Quiet now! This governance token could be the sleeping giant of the crypto world... In the next bull market, this "DeFi 2.0" powerhouse might soar 10x... 50x... perhaps even 100x.

Harris campaign releases new ad to highlight plans to build 3 million homes, reduce inflation

WASHINGTON (AP) — Vice President has a new advertising push to draw attention to her plan to build 3 million new homes over four years, a move designed to contain that also draws a sharp contrast to Republican .

Maryland awards contract for Francis Scott Key Bridge rebuild after deadly collapse

BALTIMORE (AP) — Maryland transportation leaders on Thursday approved a contract for rebuilding the Francis Scott Key Bridge several months after the 1.6-mile (2.6-kilometer) steel span of a massive container ship that lost power and crashed into one of its supporting columns.

What Smart Investors Are Doing to Profit From the Election - Ad

While millions of Americans are fighting over who they want to win the presidential election... A small group of folks are quietly positioning themselves to profit from it by following a simple election playbook.

Stakeholder in Trump's Truth Social parent company wins court ruling over share transfer

DOVER, Del. (AP) — A federal judge in Delaware has ruled in favor of a firm seeking assurance that it will be able to sell its minority stake in the parent company of former president Donald Trump’s .

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service